Replies to post #207155 on Innovation Pharmaceuticals Inc (IPIX)

[Amatuer17]

R we screwed - the results do not seems that attractive compared to earlier results

42.8% vs 60% placebo - good but not flying colors as predicted over last week - will the balloon deflate?

[BooDog]

Brilacidin-OM Called a “Top Contender” in Oral Mucositis Market



Brilacidin






A recent online article—"A Billion Dollar Market Just Waiting for a New Oral Mucositis Drug”—published by Baystreet.ca favorably mentions Brilacidin-OM as one of five promising drug candidates—the “Top Contenders”—targeting the Oral Mucositis (OM) market.

Innovation Pharmaceuticals has completed its randomized double-blind Phase 2 Trial of Brilacidin-OM (see NCT02324335), with topline results having been released.

Results revealed a clear reduction in the incidence of Severe OM (WHO Grade ≥ 3) in patients treated with Brilacidin-OM as compared to those on placebo. Brilacidin also appeared generally safe and well-tolerated across the full safety population.

The Company is now preparing to move the Brilacidin-OM program forward.





Baystreet 2.PNG




“
Take note that Innovation Pharma and Enzychem have primary endpoints of “incidence” of OM. This is an important distinction between those looking at “duration” as the primary endpoint because it means that the companies are trying to prevent severe OM in the first place, rather than just trying to moderate the time patients must deal with severe OM.
— Source: Baystreet.ca "A Billion Dollar Market Just Waiting for a New Oral Mucositis Drug”


On the Bloog
https://www.ipharminc.com/new-blog/2017/12/11/brilacidin-om-called-a-top-contender-in-oral-mucositis-market


Looks like we're setting up to rock and roll NR. Pre market news is rolling!!!

[To infinity and beyond!]

hmmm

results whittled down to 39 patients? with a 37% rate of severe mucositis?

How to square this with the interim??!? the initial 22?

[To infinity and beyond!]

2 of 9, then 5 of 10?

are they really saying that from 22 patients to 39 patients:

initially 2 of 9, next group 5 of 10 to reach the reported total 7 of 19 with severe mucositis. 2 of 9 then 5 of 10???